Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the dose of CHF 4226 (carmoterol) that should be
given once a day to patients with COPD in order for the effect to last for 24 hours.